GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Northeast Pharmaceutical Group Co 000597.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

4.41

-0.45%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Northeast Pharmaceutical Group Co

Its shares trade on Shenzhen under the ticker 000597.SZ. It has been listed since 23 May 1996. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.07bn and net income of CN¥260.1m. At that date it held total assets of CN¥12.89bn and shareholders' equity of CN¥5.53bn.

Northeast Pharmaceutical Group Co., Ltd. engages in the manufacturing and sales of pharmaceutical products. The company is headquartered in Shenyang, Liaoning. The firm's main products include bulk pharmaceutical chemicals (BPCs), formulations and bio-diagnostic reagents. The firm is also involved in the pharmaceutical engineering business through its subsidiaries. The firm mainly conducts its business in domestic market and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
23 May 1996
Employees
6,694

Leadership

Pay as last reported

  • Mr. Kai ZhouChairman of the Board, since 2003CN¥1.3m
  • Ms. Yana ZhouChief Financial Officer
  • Mr. Yonggang CaiGeneral Manager
  • Mr. Xiao FengDeputy General Manager
  • Mr. Guanghui JiDeputy General ManagerCN¥617,100
  • Mr. Yan LiuDeputy General ManagerCN¥630,500
  • Mr. Xiaojia YanSecretary of the Board
  • Mr. Xinhua AoDirector
  • Mr. Jianmin GuoDirector, since 2021CN¥164,500
  • Mr. Chengren HuangDirector
  • Mr. Zhihua HuangDirector
  • Mr. Zhaochun TanDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • The company employs 6,694 full-time staff members.
  • It manufactures bulk pharmaceutical chemicals and formulations.
  • Business operations span domestic and overseas markets.

Weaknesses

  • The source description is explicitly treated as untrusted.
  • Specific financial data points are not provided.
  • Reliable internal metrics are absent from the text.

Opportunities

  • The firm is involved in pharmaceutical engineering via subsidiaries.
  • Bio-diagnostic reagents represent a product category.
  • Overseas markets offer potential expansion avenues.

Threats

  • Competitors in the pharmaceutical sector are numerous.
  • Regulatory changes in China may impact operations.
  • Market fluctuations affect bulk chemical sales.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.